EyePoint Pharmaceuticals Q2 2019 Earnings Report

Total Revenue
$7.21M
Previous year: $933K
+672.8%
EPS
-$1.1
Previous year: -$1.3
-15.4%
R&D Expenses
$3.96M
Operating Expenses
$17.4M

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals Revenue by Segment